The hepatitis B virus (HBV) is a small enveloped DNA virus, which primarily infects hepatocytes and causes acute and persistent liver disease. Epidemiological studies have provided overwhelming evidence for a causal role of chronic HBV infection in the development of hepatocellular carcinoma, but the molecular mechanisms underlying virally-induced tumourigenesis remain largely debated. In the absence of a dominant oncogene encoded by the HBV genome, indirect roles have been proposed, including insertional activation of cellular cancer-related genes by HBV DNA integration, induction of genetic instability by viral integration or by the regulatory protein HBx, and long-term effects of viral proteins in enhancing immune-mediated liver disease....
International audienceHepatocellular carcinoma (HCC) is the most frequent primary malignancy of the ...
International audienceHepatocellular carcinoma (HCC) is the most frequent primary malignancy of the ...
Chronic hepatitis B progresses across a spectrum of asymtomatic carriers, active hepatitis, and live...
The hepatitis B virus (HBV) is a small enveloped DNA virus, which primarily infects hepatocytes and ...
Hepatitis B virus (HBV) contributes to hepatocellular carcinoma (HCC) development through direct and...
Of many viral causes of human cancer, few are of greater global importance than the hepatitis B viru...
Chronic hepatitis B virus (HBV) infection is the primary risk factor for the development of hepatoce...
Hepatocellular carcinoma (HCC) ranks as the third leading cause of cancer-related death worldwide wi...
none3Chronic viral infection is the most important oncogenetic factor, and hepatitis B virus (HBV) p...
As obligate intracellular parasites, viruses need a host cell to provide a milieu favorable to viral...
none3Chronic viral infection is the most important oncogenetic factor, and hepatitis B virus (HBV) p...
Hepatocellular carcinoma (HCC) is a worldwide health issue that has started receiving attention but ...
Viral hepatitis is one of the main causes leading to hepatocellular carcinoma (HCC). The continued r...
none3Chronic viral infection is the most important oncogenetic factor, and hepatitis B virus (HBV) p...
Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which can cause liv...
International audienceHepatocellular carcinoma (HCC) is the most frequent primary malignancy of the ...
International audienceHepatocellular carcinoma (HCC) is the most frequent primary malignancy of the ...
Chronic hepatitis B progresses across a spectrum of asymtomatic carriers, active hepatitis, and live...
The hepatitis B virus (HBV) is a small enveloped DNA virus, which primarily infects hepatocytes and ...
Hepatitis B virus (HBV) contributes to hepatocellular carcinoma (HCC) development through direct and...
Of many viral causes of human cancer, few are of greater global importance than the hepatitis B viru...
Chronic hepatitis B virus (HBV) infection is the primary risk factor for the development of hepatoce...
Hepatocellular carcinoma (HCC) ranks as the third leading cause of cancer-related death worldwide wi...
none3Chronic viral infection is the most important oncogenetic factor, and hepatitis B virus (HBV) p...
As obligate intracellular parasites, viruses need a host cell to provide a milieu favorable to viral...
none3Chronic viral infection is the most important oncogenetic factor, and hepatitis B virus (HBV) p...
Hepatocellular carcinoma (HCC) is a worldwide health issue that has started receiving attention but ...
Viral hepatitis is one of the main causes leading to hepatocellular carcinoma (HCC). The continued r...
none3Chronic viral infection is the most important oncogenetic factor, and hepatitis B virus (HBV) p...
Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which can cause liv...
International audienceHepatocellular carcinoma (HCC) is the most frequent primary malignancy of the ...
International audienceHepatocellular carcinoma (HCC) is the most frequent primary malignancy of the ...
Chronic hepatitis B progresses across a spectrum of asymtomatic carriers, active hepatitis, and live...